Evidence map›Paper›PMID 25989750›Full record

ReviewPurinergic signalling2015

Purinergic signalling during development and ageing.

Geoffrey Burnstock, Nicholas Dale

Open access · bronzeAbstract readReview
In one paragraph

Review in Purinergic signalling, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
5.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. CaInternational journal of molecular sciences · 2023
    Article
  9. Review
  10. Article
  11. Review
  12. Energy drinks at adolescence: Awareness or unawareness?Frontiers in behavioral neuroscience · 2023
    Review
  13. Editorial: Alcohol and energy drinks: is this a really good mix?Frontiers in behavioral neuroscience · 2023
    Article
  14. Article
  15. Purinergic Signaling in Endometriosis-Associated Pain.International journal of molecular sciences · 2020
    Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Geoffrey BurnstockAutonomic Neuroscience Centre, University College Medical School, Rowland Hill Street, London, NW3 2PF, UK, g.burnstock@ucl.ac.uk.
Nicholas Dale
Roland Hill (United Kingdom) · GBUniversity of Warwick · GB

Funding

Medical Research Council MR/J003786/1
6 · The paper itself

Abstract

Extracellular purines and pyrimidines play major roles during embryogenesis, organogenesis, postnatal development and ageing in vertebrates, including humans. Pluripotent stem cells can differentiate into three primary germ layers of the embryo but may also be involved in plasticity and repair of the adult brain. These cells express the molecular components necessary for purinergic signalling, and their developmental fates can be manipulated via this signalling pathway. Functional P1, P2Y and P2X receptor subtypes and ectonucleotidases are involved in the development of different organ systems, including heart, blood vessels, skeletal muscle, urinary bladder, central and peripheral neurons, retina, inner ear, gut, lung and vas deferens. The importance of purinergic signalling in the ageing process is suggested by changes in expression of A1 and A2 receptors in old rat brains and reduction of P2X receptor expression in ageing mouse brain. By contrast, in the periphery, increases in expression of P2X3 and P2X4 receptors are seen in bladder and pancreas.

Indexed as

PurinesAdultAgingAnimalsEmbryonic DevelopmentFemaleHumansPregnancyReceptors, PurinergicSignal TransductionStem CellsPurinesReceptors, Purinergic

Identifiers

PMID25989750
PMCPMC4529855
OpenAlexW1891613450

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.